PATENT CLAIM ANALYSIS

Application Number: 15861586
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "349000"]

Abstract:
The present invention provides a compound which is: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alaninate or a salt, hydrate or solvate thereof. The present invention also provides a pharmaceutical composition comprising the compound together with one or more pharmaceutically acceptable carriers and/or excipients. The compound and composition are useful for inhibiting the activity of a p38 MAP kinase enzyme. As such they may be used in the treatment of a autoimmune or inflammatory disease, or a cell proliferative disease. In addition, the invention provides an acid produced by hydrolysis of the ester group of the compound of the invention. The acid is N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alanine.

Claim (Index 13):
A method of treating, ameliorating or reducing the incidence of cell proliferative disease in a subject, which method comprises administering to said subject an effective amount of a compound as defined in  claim 1  or a composition as defined in  claim 2 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.80488
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15183612', '14436404', '12299333', '12867774', '13707326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7713291620363035
- 35 USC 102 Novelty (BERT): 0.5469870587975264
- Combined Prediction Score: 0.7488949517124258
- Mean Citation Score: 334.035562
- Max Citation Score: 390.14536
- Similarity Product: 243.96384292141445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test